This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Osaka University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Kota Iwahori: Innovator in Tumor Immunotherapy
Introduction
Kota Iwahori is a notable inventor based in Suita, Japan. He has made significant contributions to the field of tumor immunotherapy, particularly through his innovative methods for predicting treatment efficacy. His work is essential in advancing cancer treatment and improving patient outcomes.
Latest Patents
Kota Iwahori holds a patent titled "Method for predicting effect of tumor immunotherapy using tumor cytotoxic activity of peripheral blood T cells as index." This patent outlines a method that provides a companion diagnostic for predicting the effect of tumor immunotherapy. The process involves several steps, including the collection of peripheral blood mononuclear cells from a patient and their interaction with tumor cells in vitro. The effectiveness of the immunotherapy is determined based on whether the tumor cells are damaged during this interaction.
Career Highlights
Kota Iwahori is affiliated with Osaka University, where he conducts research and develops innovative solutions in the field of immunotherapy. His work has garnered attention for its potential to enhance the effectiveness of cancer treatments.
Collaborations
Hisashi Wada is a notable coworker of Kota Iwahori, contributing to the collaborative efforts in their research endeavors.
Conclusion
Kota Iwahori's contributions to tumor immunotherapy through his patented methods highlight his role as an innovator in the medical field. His work continues to pave the way for advancements in cancer treatment and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
